Published on 28 Apr 2024 on Simply Wall St. via Yahoo Finance
With 53% ownership, Vir Biotechnology, Inc. (NASDAQ:VIR) boasts of strong institutional backing
Key Insights
Institutions' substantial holdings in Vir Biotechnology implies that they have significant influence over the company's share price55% of the business is held by the top 6 shareholders Recent sales by insiders
Every investor in Vir Biotechnology, Inc. (NASDAQ:VIR) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 53% to be precise, is institutions. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).